Puritan at ECCMID
 

Neogen's New Lateral Flow Reader, Analyses and Stores Results

Neogen has developed a revolutionary method to read, store and analyze results from lateral flow tests. Neogen’s new Reveal® AccuScan™ System is the only lateral flow test reader available on the market. AccuScan provides an easy method to objectively read, store, and analyze results from Neogen’s Reveal line of lateral flow tests for Listeria, E. coli O157:H7, Salmonella, GMOs, mycotoxins, food allergens and ruminant material in animal feed.

The lateral flow tests are quick and easy to use and now the AccuScan reader eliminates any subjectivity with reading the result and also provides a permanent record of the results that may be required in order to comply with a company's HACCP plan.


The AccuScan system consists of a lateral flow test reader combined with a personal data assistant (PDA), and intuitive data management computer software. By inserting a test device into the reader and activating, the instrument takes a digital photograph of the test strip’s results area. The reader then interprets the test’s results, and if a line is detected, displays a line weight score. This process eliminates the subjectivity associated with lateral flow test interpretation, and provides an objective, traceable record of the test result. Windows-based AccuScan Data Manager PC software allows users to analyze test data and view actual images of the lateral flow strips captured during testing.

Among the products AccuScan has been engineered to read include Neogen’s new Reveal for Aflatoxin lateral flow test, the easiest and quickest test available for aflatoxin; Reveal for E. coli O157:H7; Reveal for Peanut Allergen, a simple lateral flow test to detect peanut residues in 10 minutes or less; and the remainder of Neogen’s lateral flow tests for pathogens, GMOs, and ruminant material.




NOTE: This item is from our 'historic' database and may contain information which is not up to date.

Source : Neogen Corp. View Company Information

Posted on July 5, 2004